Medicinal Chemistry Team

Dr Graham Wynne
Medicinal Chemistry Advisor

Dr Bob Westwood
Medicinal Chemistry Advisor

Dr Peter Kennewell
Medicinal Chemistry Advisor


Dr Carole Bataille (PDRA)
Identification of new anti-cancer agents; funded by LLR, collaboration with Prof Terry Rabbitts.

Dr Liam Bromhead (PDRA)
Development of pro-neurogenic small molecules for use as therapies for Alzheimer’s and other neurodegenerative disease; funded by OxStem Neuro.

Dr Tom Carter (PDRA)
Development of pro-neurogenic small molecules for use as therapies for Alzheimer’s and other neurodegenerative disease; funded by OxStem Neuro.

Dr Thomas Cogswell (PDRA)
Identification and optimisation of small molecules which modulate cancer stem-like cells to improve therapeutic outcome; funded by OxStem Oncology.

Dr Maria Chatzopoulou (PDRA)
Optimisation of small molecule utrophin modulators for the treatment of Duchenne Muscular Dystrophy; funded by Summit Therapeutics.

Dr Enrico Emer (PDRA)
Optimisation of small molecule utrophin modulators for the treatment of Duchenne Muscular Dystrophy; funded by Summit Therapeutics.

Dr Sebastien Galen (PDRA)
Identification of small molecules that activate retinal stem cells to induce tissue regeneration or repair; funded by OxStem Ocular.

Dr Irene Georgiou (PDRA)
Identification and optimisation of small molecules which induce cardiovascular regeneration; funded by OxStem Cardio.

Dr Chris Greaves (PDRA)
Identification and optimisation of small molecules which induce cardiovascular regeneration; funded by OxStem Cardio.

Dr Morgan Jay-Smith (PDRA)
Development of small molecules to inhibit the aggregation and differentiation of induced pluripotent stem cells within in vitro cultures; funded by OxStem 4D.

Dr Laia Josa-Culleré (PDRA)
Identification and optimisation of small molecules which modulate cancer stem-like cells to improve therapeutic outcome; funded by OxStem Oncology.

Dr Katrina Madden (PDRA)
Development of pro-neurogenic small molecules for use as therapies for Alzheimer’s and other neurodegenerative disease; funded by OxStem Neuro.

Dr Laura Mola Sola (PDRA)
Identification of small molecules that activate retinal stem cells to induce tissue regeneration or repair; funded by OxStem Ocular.

Dr Jessica Rowley (PDRA)
Optimisation of small molecule utrophin modulators for the treatment of Duchenne Muscular Dystrophy; funded by Summit Therapeutics.

Dr Laurence Silpa (PDRA)
Development of small molecules to inhibit the aggregation and differentiation of induced pluripotent stem cells within in vitro cultures; funded by OxStem 4D.

Dr Aini Vuorinen (PDRA)
Study of the mechanism of action of small molecule utrophin modulators; funded by Summit Therapeutics.

 

 

 

 


Site Map | Printable View | © 2008 - 2017 Department of Chemistry - University of Oxford

Powered by mojoPortal | HTML 5 | CSS | Design by styleshout